| Previous Close | 74.39 |
| Open | 74.72 |
| Bid | 73.74 x 200 |
| Ask | 73.83 x 1300 |
| Day's Range | 73.62 - 75.29 |
| 52 Week Range | 63.76 - 84.15 |
| Volume | 8,277,262 |
| Avg. Volume | 8,646,880 |
| Market Cap | 96.36B |
| Beta | 0.96 |
| PE Ratio (TTM) | 7.79 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Dividend & Yield | 2.08 (2.82%) |
| Ex-Dividend Date | 2017-06-14 |
| 1y Target Est | N/A |
- SmarterAnalyst•3 hours ago
What To Look For In Gilead Sciences, Inc. (GILD) Earnings
Healthcare giant Gilead Sciences, Inc. (NASDAQ:GILD) is gearing up for another quarterly report after the closing bell on Wednesday. This time, the report will cover results from the second quarter of fiscal 2017.
Zacks•6 hours agoDrug Stocks Q2 Earnings Releases on Jul 26: GILD, VRTX, GSK
We have three pharma giants that are set to report second-quarter results on Jul 26. Let's see how things are shaping up for this quarter.
- Zacks•9 hours ago
Is a Surprise Coming for Gilead Sciences (GILD) This Earnings Season?
Gilead Sciences (GILD) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP.
